1h Free Analyst Time
The global non-alcoholic steatohepatitis (nash) market is forecasted to grow by USD 40.05 billion during 2025-2030, accelerating at a CAGR of 47.1% during the forecast period. The report on the global non-alcoholic steatohepatitis (nash) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of obesity and metabolic syndrome, rise in global aging population, advancements in diagnostic technologies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global non-alcoholic steatohepatitis (nash) market is segmented as below:
By Distribution Channel
- Offline
- Online
By Application
- Diagnosis
- Treatment
By Product
- Vitamin E and pioglitazone
- Obeticholic acid (OCA)
- Lanifibranor
- Others
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- The Netherlands
- Spain
- Russia
- Asia
- Rest of World (RoW)
The report on the global non-alcoholic steatohepatitis (nash) market covers the following areas:
- Global non-alcoholic steatohepatitis (nash) market sizing
- Global non-alcoholic steatohepatitis (nash) market forecast
- Global non-alcoholic steatohepatitis (nash) market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Non-Alcoholic Steatohepatitis (NASH) Market 2020 - 2024
- Historic Market Size - Data Table on Global Non-Alcoholic Steatohepatitis (NASH) Market 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 The Impact of AI on the Global Non-Alcoholic Steatohepatitis (NASH) Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Distribution Channel
8.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Offline - Market size and forecast 2025-2030 ($ million)
- Data Table on Offline - Market size and forecast 2025-2030 ($ million)
- Chart on Offline - Year-over-year growth 2025-2030 (%)
- Data Table on Offline - Year-over-year growth 2025-2030 (%)
- Chart on Online - Market size and forecast 2025-2030 ($ million)
- Data Table on Online - Market size and forecast 2025-2030 ($ million)
- Chart on Online - Year-over-year growth 2025-2030 (%)
- Data Table on Online - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Application
9.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
- Chart on Comparison by Application
- Data Table on Comparison by Application
- Chart on Diagnosis - Market size and forecast 2025-2030 ($ million)
- Data Table on Diagnosis - Market size and forecast 2025-2030 ($ million)
- Chart on Diagnosis - Year-over-year growth 2025-2030 (%)
- Data Table on Diagnosis - Year-over-year growth 2025-2030 (%)
- Chart on Treatment - Market size and forecast 2025-2030 ($ million)
- Data Table on Treatment - Market size and forecast 2025-2030 ($ million)
- Chart on Treatment - Year-over-year growth 2025-2030 (%)
- Data Table on Treatment - Year-over-year growth 2025-2030 (%)
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by Product
10.1 Market segments
- Chart on Product - Market share 2025-2030 (%)
- Data Table on Product - Market share 2025-2030 (%)
- Chart on Comparison by Product
- Data Table on Comparison by Product
- Chart on Vitamin E and pioglitazone - Market size and forecast 2025-2030 ($ million)
- Data Table on Vitamin E and pioglitazone - Market size and forecast 2025-2030 ($ million)
- Chart on Vitamin E and pioglitazone - Year-over-year growth 2025-2030 (%)
- Data Table on Vitamin E and pioglitazone - Year-over-year growth 2025-2030 (%)
- Chart on Obeticholic acid (OCA) - Market size and forecast 2025-2030 ($ million)
- Data Table on Obeticholic acid (OCA) - Market size and forecast 2025-2030 ($ million)
- Chart on Obeticholic acid (OCA) - Year-over-year growth 2025-2030 (%)
- Data Table on Obeticholic acid (OCA) - Year-over-year growth 2025-2030 (%)
- Chart on Lanifibranor - Market size and forecast 2025-2030 ($ million)
- Data Table on Lanifibranor - Market size and forecast 2025-2030 ($ million)
- Chart on Lanifibranor - Year-over-year growth 2025-2030 (%)
- Data Table on Lanifibranor - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on Russia - Market size and forecast 2025-2030 ($ million)
- Data Table on Russia - Market size and forecast 2025-2030 ($ million)
- Chart on Russia - Year-over-year growth 2025-2030 (%)
- Data Table on Russia - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Australia - Market size and forecast 2025-2030 ($ million)
- Data Table on Australia - Market size and forecast 2025-2030 ($ million)
- Chart on Australia - Year-over-year growth 2025-2030 (%)
- Data Table on Australia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Rising prevalence of obesity and metabolic syndrome
- Rise in global aging population
- Advancements in diagnostic technologies
- Lack of approved therapies
- Lack of awareness of non-alcoholic steatohepatitis (NASH) treatment
- Long-term outcomes and prognosis
- Impact of drivers and challenges in 2025 and 2030
- Rising patient engagement and education
- Emergence of combination therapies
- Integration of digital health solutions
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- Cirius Therapeutics - Overview
- Cirius Therapeutics - Product / Service
- Cirius Therapeutics - Key offerings
- SWOT
- GENFIT SA - Overview
- GENFIT SA - Product / Service
- GENFIT SA - Key offerings
- SWOT
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- SWOT
- Intercept Pharmaceuticals Inc. - Overview
- Intercept Pharmaceuticals Inc. - Product / Service
- Intercept Pharmaceuticals Inc. - Key offerings
- SWOT
- Inventiva S.A. - Overview
- Inventiva S.A. - Product / Service
- Inventiva S.A. - Key offerings
- SWOT
- Madrigal Pharmaceuticals Inc. - Overview
- Madrigal Pharmaceuticals Inc. - Product / Service
- Madrigal Pharmaceuticals Inc. - Key offerings
- SWOT
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- Prometheus Laboratories - Overview
- Prometheus Laboratories - Product / Service
- Prometheus Laboratories - Key offerings
- SWOT
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key news
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- Takeda Pharmaceutical Ltd. - Overview
- Takeda Pharmaceutical Ltd. - Product / Service
- Takeda Pharmaceutical Ltd. - Key news
- Takeda Pharmaceutical Ltd. - Key offerings
- SWOT
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Application
Exhibit 7: Executive Summary - Chart on Market Segmentation by Product
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Non-Alcoholic Steatohepatitis (NASH) Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 39: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Distribution Channel
Exhibit 41: Data Table on Comparison by Distribution Channel
Exhibit 42: Chart on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Online - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Online - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Distribution Channel ($ million)
Exhibit 51: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 52: Chart on Application - Market share 2025-2030 (%)
Exhibit 53: Data Table on Application - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Application
Exhibit 55: Data Table on Comparison by Application
Exhibit 56: Chart on Diagnosis - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Diagnosis - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Diagnosis - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Diagnosis - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Treatment - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Treatment - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Treatment - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Treatment - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by Application ($ million)
Exhibit 65: Data Table on Market opportunity by Application ($ million)
Exhibit 66: Chart on Product - Market share 2025-2030 (%)
Exhibit 67: Data Table on Product - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Product
Exhibit 69: Data Table on Comparison by Product
Exhibit 70: Chart on Vitamin E and pioglitazone - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Vitamin E and pioglitazone - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Vitamin E and pioglitazone - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Vitamin E and pioglitazone - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Obeticholic acid (OCA) - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Obeticholic acid (OCA) - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Obeticholic acid (OCA) - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Obeticholic acid (OCA) - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Lanifibranor - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Lanifibranor - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Lanifibranor - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Lanifibranor - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 86: Market opportunity by Product ($ million)
Exhibit 87: Data Table on Market opportunity by Product ($ million)
Exhibit 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 89: Chart on Market share by geography 2025-2030 (%)
Exhibit 90: Data Table on Market share by geography 2025-2030 (%)
Exhibit 91: Chart on Geographic comparison
Exhibit 92: Data Table on Geographic comparison
Exhibit 93: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 96: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 97: Chart on Regional Comparison - North America
Exhibit 98: Data Table on Regional Comparison - North America
Exhibit 99: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Regional Comparison - Europe
Exhibit 116: Data Table on Regional Comparison - Europe
Exhibit 117: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Regional Comparison - Asia
Exhibit 150: Data Table on Regional Comparison - Asia
Exhibit 151: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 209: Market opportunity by geography ($ million)
Exhibit 210: Data Tables on Market opportunity by geography ($ million)
Exhibit 211: Impact of drivers and challenges in 2025 and 2030
Exhibit 212: Overview on criticality of inputs and factors of differentiation
Exhibit 213: Overview on factors of disruption
Exhibit 214: Impact of key risks on business
Exhibit 215: Companies covered
Exhibit 216: Company ranking index
Exhibit 217: Matrix on companies position and classification
Exhibit 218: AbbVie Inc. - Overview
Exhibit 219: AbbVie Inc. - Product / Service
Exhibit 220: AbbVie Inc. - Key news
Exhibit 221: AbbVie Inc. - Key offerings
Exhibit 222: SWOT
Exhibit 223: Bristol Myers Squibb Co. - Overview
Exhibit 224: Bristol Myers Squibb Co. - Product / Service
Exhibit 225: Bristol Myers Squibb Co. - Key news
Exhibit 226: Bristol Myers Squibb Co. - Key offerings
Exhibit 227: SWOT
Exhibit 228: Cirius Therapeutics - Overview
Exhibit 229: Cirius Therapeutics - Product / Service
Exhibit 230: Cirius Therapeutics - Key offerings
Exhibit 231: SWOT
Exhibit 232: GENFIT SA - Overview
Exhibit 233: GENFIT SA - Product / Service
Exhibit 234: GENFIT SA - Key offerings
Exhibit 235: SWOT
Exhibit 236: Gilead Sciences Inc. - Overview
Exhibit 237: Gilead Sciences Inc. - Product / Service
Exhibit 238: Gilead Sciences Inc. - Key news
Exhibit 239: Gilead Sciences Inc. - Key offerings
Exhibit 240: SWOT
Exhibit 241: Intercept Pharmaceuticals Inc. - Overview
Exhibit 242: Intercept Pharmaceuticals Inc. - Product / Service
Exhibit 243: Intercept Pharmaceuticals Inc. - Key offerings
Exhibit 244: SWOT
Exhibit 245: Inventiva S.A. - Overview
Exhibit 246: Inventiva S.A. - Product / Service
Exhibit 247: Inventiva S.A. - Key offerings
Exhibit 248: SWOT
Exhibit 249: Madrigal Pharmaceuticals Inc. - Overview
Exhibit 250: Madrigal Pharmaceuticals Inc. - Product / Service
Exhibit 251: Madrigal Pharmaceuticals Inc. - Key offerings
Exhibit 252: SWOT
Exhibit 253: Merck and Co. Inc. - Overview
Exhibit 254: Merck and Co. Inc. - Business segments
Exhibit 255: Merck and Co. Inc. - Key news
Exhibit 256: Merck and Co. Inc. - Key offerings
Exhibit 257: Merck and Co. Inc. - Segment focus
Exhibit 258: SWOT
Exhibit 259: Novo Nordisk AS - Overview
Exhibit 260: Novo Nordisk AS - Business segments
Exhibit 261: Novo Nordisk AS - Key offerings
Exhibit 262: Novo Nordisk AS - Segment focus
Exhibit 263: SWOT
Exhibit 264: Pfizer Inc. - Overview
Exhibit 265: Pfizer Inc. - Product / Service
Exhibit 266: Pfizer Inc. - Key news
Exhibit 267: Pfizer Inc. - Key offerings
Exhibit 268: SWOT
Exhibit 269: Prometheus Laboratories - Overview
Exhibit 270: Prometheus Laboratories - Product / Service
Exhibit 271: Prometheus Laboratories - Key offerings
Exhibit 272: SWOT
Exhibit 273: Siemens Healthineers AG - Overview
Exhibit 274: Siemens Healthineers AG - Business segments
Exhibit 275: Siemens Healthineers AG - Key news
Exhibit 276: Siemens Healthineers AG - Key offerings
Exhibit 277: Siemens Healthineers AG - Segment focus
Exhibit 278: SWOT
Exhibit 279: Takeda Pharmaceutical Ltd. - Overview
Exhibit 280: Takeda Pharmaceutical Ltd. - Product / Service
Exhibit 281: Takeda Pharmaceutical Ltd. - Key news
Exhibit 282: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 283: SWOT
Exhibit 284: Zydus Lifesciences Ltd. - Overview
Exhibit 285: Zydus Lifesciences Ltd. - Business segments
Exhibit 286: Zydus Lifesciences Ltd. - Key news
Exhibit 287: Zydus Lifesciences Ltd. - Key offerings
Exhibit 288: Zydus Lifesciences Ltd. - Segment focus
Exhibit 289: SWOT
Exhibit 290: Inclusions checklist
Exhibit 291: Exclusions checklist
Exhibit 292: Currency conversion rates for US$
Exhibit 293: Research methodology
Exhibit 294: Information sources
Exhibit 295: Data validation
Exhibit 296: Validation techniques employed for market sizing
Exhibit 297: Data synthesis
Exhibit 298: 360 degree market analysis
Exhibit 299: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Application
Exhibit 7: Executive Summary - Chart on Market Segmentation by Product
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Non-Alcoholic Steatohepatitis (NASH) Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 39: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Distribution Channel
Exhibit 41: Data Table on Comparison by Distribution Channel
Exhibit 42: Chart on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Offline - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Offline - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Online - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Online - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Online - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Distribution Channel ($ million)
Exhibit 51: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 52: Chart on Application - Market share 2025-2030 (%)
Exhibit 53: Data Table on Application - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Application
Exhibit 55: Data Table on Comparison by Application
Exhibit 56: Chart on Diagnosis - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Diagnosis - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Diagnosis - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Diagnosis - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Treatment - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Treatment - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Treatment - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Treatment - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by Application ($ million)
Exhibit 65: Data Table on Market opportunity by Application ($ million)
Exhibit 66: Chart on Product - Market share 2025-2030 (%)
Exhibit 67: Data Table on Product - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Product
Exhibit 69: Data Table on Comparison by Product
Exhibit 70: Chart on Vitamin E and pioglitazone - Market size and forecast 2025-2030 ($ million)
Exhibit 71: Data Table on Vitamin E and pioglitazone - Market size and forecast 2025-2030 ($ million)
Exhibit 72: Chart on Vitamin E and pioglitazone - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Vitamin E and pioglitazone - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Obeticholic acid (OCA) - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Obeticholic acid (OCA) - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Obeticholic acid (OCA) - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Obeticholic acid (OCA) - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Lanifibranor - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Lanifibranor - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Lanifibranor - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Lanifibranor - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 86: Market opportunity by Product ($ million)
Exhibit 87: Data Table on Market opportunity by Product ($ million)
Exhibit 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 89: Chart on Market share by geography 2025-2030 (%)
Exhibit 90: Data Table on Market share by geography 2025-2030 (%)
Exhibit 91: Chart on Geographic comparison
Exhibit 92: Data Table on Geographic comparison
Exhibit 93: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 96: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 97: Chart on Regional Comparison - North America
Exhibit 98: Data Table on Regional Comparison - North America
Exhibit 99: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Regional Comparison - Europe
Exhibit 116: Data Table on Regional Comparison - Europe
Exhibit 117: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Regional Comparison - Asia
Exhibit 150: Data Table on Regional Comparison - Asia
Exhibit 151: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 209: Market opportunity by geography ($ million)
Exhibit 210: Data Tables on Market opportunity by geography ($ million)
Exhibit 211: Impact of drivers and challenges in 2025 and 2030
Exhibit 212: Overview on criticality of inputs and factors of differentiation
Exhibit 213: Overview on factors of disruption
Exhibit 214: Impact of key risks on business
Exhibit 215: Companies covered
Exhibit 216: Company ranking index
Exhibit 217: Matrix on companies position and classification
Exhibit 218: AbbVie Inc. - Overview
Exhibit 219: AbbVie Inc. - Product / Service
Exhibit 220: AbbVie Inc. - Key news
Exhibit 221: AbbVie Inc. - Key offerings
Exhibit 222: SWOT
Exhibit 223: Bristol Myers Squibb Co. - Overview
Exhibit 224: Bristol Myers Squibb Co. - Product / Service
Exhibit 225: Bristol Myers Squibb Co. - Key news
Exhibit 226: Bristol Myers Squibb Co. - Key offerings
Exhibit 227: SWOT
Exhibit 228: Cirius Therapeutics - Overview
Exhibit 229: Cirius Therapeutics - Product / Service
Exhibit 230: Cirius Therapeutics - Key offerings
Exhibit 231: SWOT
Exhibit 232: GENFIT SA - Overview
Exhibit 233: GENFIT SA - Product / Service
Exhibit 234: GENFIT SA - Key offerings
Exhibit 235: SWOT
Exhibit 236: Gilead Sciences Inc. - Overview
Exhibit 237: Gilead Sciences Inc. - Product / Service
Exhibit 238: Gilead Sciences Inc. - Key news
Exhibit 239: Gilead Sciences Inc. - Key offerings
Exhibit 240: SWOT
Exhibit 241: Intercept Pharmaceuticals Inc. - Overview
Exhibit 242: Intercept Pharmaceuticals Inc. - Product / Service
Exhibit 243: Intercept Pharmaceuticals Inc. - Key offerings
Exhibit 244: SWOT
Exhibit 245: Inventiva S.A. - Overview
Exhibit 246: Inventiva S.A. - Product / Service
Exhibit 247: Inventiva S.A. - Key offerings
Exhibit 248: SWOT
Exhibit 249: Madrigal Pharmaceuticals Inc. - Overview
Exhibit 250: Madrigal Pharmaceuticals Inc. - Product / Service
Exhibit 251: Madrigal Pharmaceuticals Inc. - Key offerings
Exhibit 252: SWOT
Exhibit 253: Merck and Co. Inc. - Overview
Exhibit 254: Merck and Co. Inc. - Business segments
Exhibit 255: Merck and Co. Inc. - Key news
Exhibit 256: Merck and Co. Inc. - Key offerings
Exhibit 257: Merck and Co. Inc. - Segment focus
Exhibit 258: SWOT
Exhibit 259: Novo Nordisk AS - Overview
Exhibit 260: Novo Nordisk AS - Business segments
Exhibit 261: Novo Nordisk AS - Key offerings
Exhibit 262: Novo Nordisk AS - Segment focus
Exhibit 263: SWOT
Exhibit 264: Pfizer Inc. - Overview
Exhibit 265: Pfizer Inc. - Product / Service
Exhibit 266: Pfizer Inc. - Key news
Exhibit 267: Pfizer Inc. - Key offerings
Exhibit 268: SWOT
Exhibit 269: Prometheus Laboratories - Overview
Exhibit 270: Prometheus Laboratories - Product / Service
Exhibit 271: Prometheus Laboratories - Key offerings
Exhibit 272: SWOT
Exhibit 273: Siemens Healthineers AG - Overview
Exhibit 274: Siemens Healthineers AG - Business segments
Exhibit 275: Siemens Healthineers AG - Key news
Exhibit 276: Siemens Healthineers AG - Key offerings
Exhibit 277: Siemens Healthineers AG - Segment focus
Exhibit 278: SWOT
Exhibit 279: Takeda Pharmaceutical Ltd. - Overview
Exhibit 280: Takeda Pharmaceutical Ltd. - Product / Service
Exhibit 281: Takeda Pharmaceutical Ltd. - Key news
Exhibit 282: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 283: SWOT
Exhibit 284: Zydus Lifesciences Ltd. - Overview
Exhibit 285: Zydus Lifesciences Ltd. - Business segments
Exhibit 286: Zydus Lifesciences Ltd. - Key news
Exhibit 287: Zydus Lifesciences Ltd. - Key offerings
Exhibit 288: Zydus Lifesciences Ltd. - Segment focus
Exhibit 289: SWOT
Exhibit 290: Inclusions checklist
Exhibit 291: Exclusions checklist
Exhibit 292: Currency conversion rates for US$
Exhibit 293: Research methodology
Exhibit 294: Information sources
Exhibit 295: Data validation
Exhibit 296: Validation techniques employed for market sizing
Exhibit 297: Data synthesis
Exhibit 298: 360 degree market analysis
Exhibit 299: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global non-alcoholic steatohepatitis (nash) market: AbbVie Inc., Bristol Myers Squibb Co., Cirius Therapeutics, Eli Lilly and Co., Enanta Pharmaceuticals Inc., Enzo Biochem Inc., GENFIT SA, Gilead Sciences Inc., Intercept Pharmaceuticals Inc., Inventiva S.A., Madrigal Pharmaceuticals Inc., Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Pfizer Inc., Prometheus Laboratories, Siemens Healthineers AG, Takeda Pharmaceutical Ltd., Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising patient engagement and education."
According to the report, one of the major drivers for this market is the rising prevalence of obesity and metabolic syndrome.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Bristol Myers Squibb Co.
- Cirius Therapeutics
- Eli Lilly and Co.
- Enanta Pharmaceuticals Inc.
- Enzo Biochem Inc.
- GENFIT SA
- Gilead Sciences Inc.
- Intercept Pharmaceuticals Inc.
- Inventiva S.A.
- Madrigal Pharmaceuticals Inc.
- Merck and Co. Inc.
- Novartis AG
- Novo Nordisk AS
- Pfizer Inc.
- Prometheus Laboratories
- Siemens Healthineers AG
- Takeda Pharmaceutical Ltd.
- Zydus Lifesciences Ltd.
